Meeting
2024 ASCO Gastrointestinal Cancers Symposium
A randomized phase III study comparing 2-weekly docetaxel, cisplatin and 5-FU (bDCF) with cisplatin and 5-FU (CF) in patients with metastatic or recurrent esophageal cancer: JCOG1314 (MIRACLE).
Authors
Takahiro Tsushima
Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan
Takahiro Tsushima , Shuichi Hironaka , Yasuhiro Tsubosa , Ken Kato , Motoo Nomura , Hiroki Hara , Yuko Kitagawa , Kazuo Koyanagi , Takeshi Kajiwara , Naoki Takegawa , Hisahiro Matsubara , Hideo Baba , Masaru Morita , Toru Masuzawa , Hiroko Hasegawa , Takashi Kojima , Ryunosuke Machida , Keita Sasaki , Hiroya Takeuchi , Shigenori Kadowaki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
jRCTs031180143
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 322)
DOI
10.1200/JCO.2024.42.3_suppl.322
Abstract #
322
Poster Bd #
F2
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Phase 3 randomized study comparing docetaxel-platinum with docetaxel-platinum-5 fluorouracil as neoadjuvant chemotherapy in technically unresectable oral cancer.
First Author: Ajaykumar Singh
Poster
2015 Gastrointestinal Cancers Symposium
Early tumor shrinkage (ETS) and deepness of response (DpR) in patients with metastatic esophageal cancer receiving a first-line treatment with DCF: Exploratory analysis of the JCOG0807.
First Author: Takashi Ura
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Recurrence-free survival as a surrogate for overall survival in esophageal squamous cell carcinoma: Nationwide real-world data from Japan.
First Author: Jun Okui
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Safety and efficacy of nanosomal docetaxel lipid suspension (NDLS) in patients with advanced gastric adenocarcinoma.
First Author: Vikas S. Ostwal